ArticleTranslational vision science & technology2026
Quantitative Changes in Iris Vessel Area Density During Valsalva Maneuver in Healthy Eyes.
Article in Translational vision science & technology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To quantify changes in iris vessel area density (VAD) during the Valsalva maneuver (VM) and explore their associations with anterior segment parameters in healthy subjects. Methods: This prospective cross-sectional study included 82 healthy volunteers, with one eye randomly selected for analysis. Iris VAD was quantified at baseline and during VM using optical coherence tomography angiography. Anterior segment parameters and intraocular pressure (IOP) were also assessed under both conditions. Results: Compared to baseline, significant reductions in total iris VAD were observed during VM (P = 0.029), with more pronounced decreases in the inner and outer iris regions (both P < 0.010). Concurrently, VM led to a significant elevation in IOP (P < 0.001), reductions in anterior chamber depth (P = 0.020) and volume (P < 0.001), and an increase in crystalline lens rise (P = 0.004). During VM, smaller values were observed in scleral spur angle (SSA500, P = 0.006; SSA750, P = 0.002), angle opening distance (AOD500, P = 0.014; AOD750, P = 0.001), anterior chamber angle (ACA750, P = 0.013), and trabecular-iris space area (TISA750, P = 0.004). Regression analysis revealed that axial length (AL), changes in TISA750, and changes in lens thickness were associated with VM-induced iris VAD changes (all P < 0.05). Conclusions: VM reduced iris microcirculation in healthy individuals, particularly in those with shorter AL, accompanied by structural anterior segment changes. Translational Relevance: This study provides microvascular evidence of VM-induced iris hypoperfusion and suggests that hemodynamic mechanisms contribute to anterior segment alterations during VM.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.